Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan R Hart

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2015
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator ComplexSheena M Saayman, Daniel C Lazar, Tristan A Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2021
Cryo-EM structures of PI3Kα reveal conformational changes during inhibition and activationXiao Liu, Su Yang, Jonathan R Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Inhibitor of MYC identified in a Kröhnke pyridine libraryJonathan R Hart, Amanda L Garner, Jing Yu, et al.
Bioorganic & Medicinal Chemistry|July 25, 2018
Synthetic molecules for disruption of the MYC protein-protein interfaceNicholas T Jacob, Pedro O Miranda, Ryan J Shirey, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2022
Nanobodies and chemical cross-links advance the structural and functional analysis of PI3KαJonathan R Hart, Xiao Liu, Chen Pan, et al.
Molecular Therapy. Nucleic Acids|September 17, 2018
Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMDAnna M L Coenen-Stass, Helena Sork, Sole Gatto, et al.
Cell|April 23, 2016
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block SignalingSai Krishna Athuluri-Divakar, Rodrigo Vasquez-Del Carpio, Kaushik Dutta, et al.
Bioorganic & Medicinal Chemistry|June 15, 2021
Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assayRyan J Shirey, Jonathan R Hart, BanuPriya Sridharan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
tsRNA signatures in cancerVeronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Cancer Cell|April 17, 2014
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancerNicola Valeri, Chiara Braconi, Pierluigi Gasparini, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 20, 2015
Potent and Targeted Activation of Latent HIV-1 Using the CRISPR/dCas9 Activator ComplexSheena M Saayman, Daniel C Lazar, Tristan A Scott, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2021
Cryo-EM structures of PI3Kα reveal conformational changes during inhibition and activationXiao Liu, Su Yang, Jonathan R Hart, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Inhibitor of MYC identified in a Kröhnke pyridine libraryJonathan R Hart, Amanda L Garner, Jing Yu, et al.
Bioorganic & Medicinal Chemistry|July 25, 2018
Synthetic molecules for disruption of the MYC protein-protein interfaceNicholas T Jacob, Pedro O Miranda, Ryan J Shirey, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2022
Nanobodies and chemical cross-links advance the structural and functional analysis of PI3KαJonathan R Hart, Xiao Liu, Chen Pan, et al.
Molecular Therapy. Nucleic Acids|September 17, 2018
Comprehensive RNA-Sequencing Analysis in Serum and Muscle Reveals Novel Small RNA Signatures with Biomarker Potential for DMDAnna M L Coenen-Stass, Helena Sork, Sole Gatto, et al.
Cell|April 23, 2016
A Small Molecule RAS-Mimetic Disrupts RAS Association with Effector Proteins to Block SignalingSai Krishna Athuluri-Divakar, Rodrigo Vasquez-Del Carpio, Kaushik Dutta, et al.
Bioorganic & Medicinal Chemistry|June 15, 2021
Synthetic fluorescent MYC probe: Inhibitor binding site elucidation and development of a high-throughput screening assayRyan J Shirey, Jonathan R Hart, BanuPriya Sridharan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2017
tsRNA signatures in cancerVeronica Balatti, Giovanni Nigita, Dario Veneziano, et al.
Cancer Cell|April 17, 2014
MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancerNicola Valeri, Chiara Braconi, Pierluigi Gasparini, et al.
Pageof 4